Roche Names Proposed Board Nominees for Illumina | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Following through on a plan it made public last week in connection with its $5.7 billion hostile takeover bid for Illumina, Roche today has published the names of the people it will nominate to serve on Illumina's board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.